Table 2.
Control | CHF | DCM | |
---|---|---|---|
Histological findings | |||
Cardiomyocyte hypertrophy | − | ± | + |
Cardiomyocyte elongation | − | ± | + |
Nuclear pleomorphism | − | ± | + |
Diffuse interstitial fibrosis | − | ± | + |
Myofibrillar loss | − | ± | + |
Myofibrillar disarray | − | − | − |
Vacuolization | − | − | − |
Granulomas | − | − | − |
Inflammatory cell infiltration | − | − | − |
Immunohistochemical findings of N-cadherin staining | |||
Reduction of stainability | − | − | + |
ICD widening | − | ± | + |
ICD scattering | − | − | + |
Pathological and immunohistochemical findings from the control, CHF, and DCM groups are summarized in this table. Deterioration of N-cadherin immunostaining was defined as a reduction in immunostaining relative to the control group. Moreover, ICD widening was defined as a width of 4 µm or more, and ICD scattering as 15 µm or more. The meanings of the symbols used in this table are as follows: (−): This finding is absent in most cases. (±): This finding is present in some cases. (+): This finding is present in most cases.
CHF chronic heart failure, DCM dilated cardiomyopathy, ICD intercalated disc.